In vitro experiments performed in cervical and ovarian carcinoma cells suggested that TNF-α can enhance topo-II inhibitor–mediated cancer cytotoxicity, Also, increased sensitivity of the type II topoisomerases inhibitor was notwithstanding of the TNF-α resistances (139). This evidence concerns the gene TNF and cancer.